Humanized chimeric antigen receptor (CAR)-modified T cells targeting CD19 induce remissions in children and young adults with relapsed/refractory lymphoblastic leukemia/lymphoma
Hucks, G.E., Barrett, D., Rheingold, S.R., Aplenc, R., Teachey, D.T., Callahan, C., Baniewicz, D., White, C., Talekar, M., Shaw, P., Brogdon, J.L., Young, R., Scholler, J., Marcucci, K., Chew, A., LevVolume:
19
Language:
english
Journal:
Cytotherapy
DOI:
10.1016/j.jcyt.2017.02.011
Date:
May, 2017
File:
PDF, 98 KB
english, 2017